Rositsa B Dimova

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. pmc Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis
    Rositsa B Dimova
    Weill Cornell Medical College, New York, NY 10065, USA
    Clin Infect Dis 56:806-16. 2013
  2. doi IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients
    Marija Zeremski
    Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY 10065, USA
    J Acquir Immune Defic Syndr 63:9-16. 2013
  3. pmc FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
    Marija Zeremski
    Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    BMC Gastroenterol 14:118. 2014
  4. doi Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment
    Andrew H Talal
    Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY, USA
    J Subst Abuse Treat 44:115-9. 2013
  5. doi Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance
    Marija Zeremski
    From the Division of Gastroenterology and Hepatology MZ, RBD, AHT, Weill Cornell Medical College, New York, NY Department of Biostatistics RBD, University at Buffalo, State University of New York, Buffalo, NY Addiction Research and Treatment Corporation RZ, SK, ML, Brooklyn, NY Centers for Disease Control and Prevention BDS, JEZ, Division of Viral Hepatitis, Atlanta, GA and Division of Gastroenterology, Hepatology, and Nutrition AHT, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY
    J Addict Med 8:249-57. 2014
  6. pmc Telaprevir-based treatment effects on hepatitis C virus in liver and blood
    Andrew H Talal
    Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, State University of New York at Buffalo, Buffalo, NY
    Hepatology 60:1826-37. 2014

Detail Information

Publications6

  1. pmc Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis
    Rositsa B Dimova
    Weill Cornell Medical College, New York, NY 10065, USA
    Clin Infect Dis 56:806-16. 2013
    ..We assessed the effects of different treatment approaches and services to promote HCV care among DUs as well as demographic and viral characteristics...
  2. doi IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients
    Marija Zeremski
    Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY 10065, USA
    J Acquir Immune Defic Syndr 63:9-16. 2013
    ..We sought to develop a score to predict sustained virological response (SVR) in racially diverse HIV/hepatitis C virus (HCV)-coinfected and HCV-monoinfected pegylated interferon/ribavirin-treated patients...
  3. pmc FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
    Marija Zeremski
    Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    BMC Gastroenterol 14:118. 2014
    ..Our aim was to evaluate the capacity of FibroSURE, one of the two noninvasive fibrosis indices commercially available in the United States, to identify HBV infected patients with moderate to severe fibrosis...
  4. doi Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment
    Andrew H Talal
    Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY, USA
    J Subst Abuse Treat 44:115-9. 2013
    ..Educational interventions and skill building for staff to confidently engage and support MMTP patients in HCV treatment may be necessary prerequisites for onsite HCV management in MMTPs...
  5. doi Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance
    Marija Zeremski
    From the Division of Gastroenterology and Hepatology MZ, RBD, AHT, Weill Cornell Medical College, New York, NY Department of Biostatistics RBD, University at Buffalo, State University of New York, Buffalo, NY Addiction Research and Treatment Corporation RZ, SK, ML, Brooklyn, NY Centers for Disease Control and Prevention BDS, JEZ, Division of Viral Hepatitis, Atlanta, GA and Division of Gastroenterology, Hepatology, and Nutrition AHT, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY
    J Addict Med 8:249-57. 2014
    ..We assessed the level of HCV-related knowledge and willingness to participate in HCV treatment among methadone-maintained patients...
  6. pmc Telaprevir-based treatment effects on hepatitis C virus in liver and blood
    Andrew H Talal
    Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, State University of New York at Buffalo, Buffalo, NY
    Hepatology 60:1826-37. 2014
    ..We found moderate heterogeneity between HCV RNA levels from different intrahepatic sites, indicating differences in hepatic microenvironments...